ALPS Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$332K Sell
48,116
-406
-0.8% -$3.13K ﹤0.01% 968
2025
Q4
$428K Buy
48,522
+20,597
+74% +$113K ﹤0.01% 853
2025
Q3
$139K Sell
27,925
-3,834
-12% -$17.8K ﹤0.01% 1015
2025
Q2
$150K Sell
31,759
-10,234
-24% -$44.8K ﹤0.01% 1018
2025
Q1
$193K Sell
41,993
-5,156
-11% -$24K ﹤0.01% 962
2024
Q4
$226K Buy
47,149
+3,113
+7% +$14.9K ﹤0.01% 966
2024
Q3
$207K Sell
44,036
-1,360
-3% -$7.29K ﹤0.01% 979
2024
Q2
$256K Buy
45,396
+4,812
+12% +$24.9K ﹤0.01% 923
2024
Q1
$167K Buy
40,584
+152
+0.4% +$608 ﹤0.01% 963
2023
Q4
$171K Sell
40,432
-1,965
-5% -$7.93K ﹤0.01% 947
2023
Q3
$183K Buy
42,397
+173
+0.4% +$961 ﹤0.01% 960
2023
Q2
$278K Buy
42,224
+4,814
+13% +$30.9K ﹤0.01% 912
2023
Q1
$254K Sell
37,410
-1,073
-3% -$7.54K ﹤0.01% 962
2022
Q4
$284K Buy
38,483
+7,675
+25% +$74.7K ﹤0.01% 921
2022
Q3
$304K Sell
30,808
-2,704
-8% -$28.6K ﹤0.01% 765
2022
Q2
$365K Sell
33,512
-23,943
-42% -$248K ﹤0.01% 676
2022
Q1
$650K Sell
57,455
-7,014
-11% -$92.2K 0.01% 390
2021
Q4
$1.01M Sell
64,469
-3,724
-5% -$64.9K 0.01% 355
2021
Q3
$1.17M Sell
68,193
-4,992
-7% -$87.4K 0.01% 374
2021
Q2
$1.57M Sell
73,185
-26,105
-26% -$467K 0.01% 354
2021
Q1
$1.49M Sell
99,290
-26,704
-21% -$432K 0.01% 348
2020
Q4
$1.66M Buy
125,994
+97,954
+349% +$1.18M 0.02% 333
2020
Q3
$271K Buy
+28,040
New +$300K ﹤0.01% 624
2020
Q1
Sell
-25,666
Closed -$421K 936
2019
Q4
$421K Sell
25,666
-1,116
-4% -$16.9K ﹤0.01% 542
2019
Q3
$356K Buy
26,782
+6,498
+32% +$90.6K ﹤0.01% 686
2019
Q2
$286K Sell
20,284
-1,070
-5% -$17K ﹤0.01% 851
2019
Q1
$393K Buy
+21,354
New +$487K ﹤0.01% 747
2016
Q1
Sell
-36,344
Closed -$338K 761
2015
Q4
$338K Hold
36,344
﹤0.01% 637
2015
Q3
$4.1K Buy
+36,344
New +$445K ﹤0.01% 620

Other funds holding VNDA